 Allscripts looks like a relatively solid investment bet in the healthcare IT sector that has grown its share price by 140 in the past 12 months. Share price growth has stagnated in recent months perhaps owing to a modest revenue forecast of 1.5bn in FY20 - the same as in FY20. 